Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6535
    +0.0012 (+0.18%)
     
  • OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD

    2,349.60
    +7.10 (+0.30%)
     
  • Bitcoin AUD

    96,722.67
    -1,306.29 (-1.33%)
     
  • CMC Crypto 200

    1,313.06
    -83.48 (-5.98%)
     
  • AUD/EUR

    0.6108
    +0.0035 (+0.57%)
     
  • AUD/NZD

    1.0994
    +0.0037 (+0.33%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,718.30
    +287.79 (+1.65%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,239.66
    +153.86 (+0.40%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

IQVIA Holdings (IQV) Surpasses Q1 Earnings & Revenue Estimates

IQVIA Holdings Inc. IQV reported solid first-quarter 2023 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate.

Adjusted earnings per share of $2.45 beat the Zacks Consensus Estimate of $2.41 but declined on a year-over-year basis. Total revenues of $3,652 million outpaced the Zacks Consensus Estimate of $3,608.2 million and increased 2.4% year over year on a reported basis and 4.7% on a constant-currency basis.

IQVIA Holdings Inc. Price, Consensus and EPS Surprise

 

IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. Quote

Segmental Revenues

Revenues from Technology & Analytics Solutions totaled $1,444 million, up 0.3% on a reported basis and 2.9% on a constant-currency basis.

ADVERTISEMENT

Research & Development Solutions’ revenues of $2,026 million increased 4.8% on a reported basis and 6.5% on a constant-currency basis.

Revenues from Contract Sales & Medical Solutions totaled $182 million, down 6.7% on a reported basis and 1% on a constant-currency basis.

Operating Performance

Adjusted EBITDA was $851 million, up 4.8% year over year.

Balance Sheet and Cash Flow

IQVIA exited first-quarter 2023 with cash and cash equivalents of $1,494 million compared with $1,216 million at the end of the prior quarter. Long-term debt (less current portion) was $11,833 million compared with $12,595 million at the end of the prior quarter.

IQV generated $417 million of cash from operating activities in the reported quarter, while capital expenditure was $164 million. Free cash flow was $253 million.

In the first quarter of 2023, IQV repurchased shares worth $129 million. As of Mar 31, 2023, IQVIA had $1,226 million of share repurchase authorization available.

2023 Guidance

IQVIA expects revenues between $15.15 billion and $15.40 billion (representing growth of 5.1-6.9% on a reported basis and 4.7-6.5% at constant currency).  Adjusted earnings per share are expected between $10.26 and $10.56 (up 1-3.9%). Adjusted EBITDA is anticipated between $3.625 billion and $3.695 billion.

Currently, IQVIA carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Earnings Snapshot

Equifax EFX reported better-than-expected first-quarter 2023 results. Adjusted earnings (excluding 52 cents from non-recurring items) were $1.43, beating the Zacks Consensus Estimate by 4.4% but declining 35.6% from the year-ago figure. Total revenues of $1.3 billion surpassed the consensus estimate by 1.5% but decreased 4.5% on a reported basis from the year-ago figure. The top line was down 3% on a local currency basis.

OmnicomOMC reported better-than-expected first-quarter 2023 results. OMC’s earnings of $1.56 per share beat the Zacks Consensus Estimate by 13% and our estimates by 11.4%. Earnings per share increased 12.2% year over year. Total revenues of $3.4 billion surpassed the consensus estimate by 2.3% and our estimate by 1.4%. The top line increased 1% year over year.

ManpowerGroupMAN reported lower-than-expected first-quarter 2023 results. First-quarter adjusted earnings of $1.61 per share lagged the consensus mark by 0.6% but met our estimate. The bottom line declined 14.4% year over year, impacted by restructuring costs and foreign currency fluctuations. Revenues of $4.8 billion missed the consensus mark by 1.3% and our estimate by a slight margin. The top line decreased 7.6% year over year on a reported basis. Revenues decreased 2.2% on a constant-currency basis.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ManpowerGroup Inc. (MAN) : Free Stock Analysis Report

Omnicom Group Inc. (OMC) : Free Stock Analysis Report

Equifax, Inc. (EFX) : Free Stock Analysis Report

IQVIA Holdings Inc. (IQV) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research